Skip to Content

Direxion Moonshot Innovators ETF MOON

Medalist Rating as of | See Direxion Investment Hub

Morningstar’s Analysis MOON

Will MOON outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A sound investment process and strong management team underpin Direxion Moonshot Innovators ETF's Morningstar Medalist Rating of Silver.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a cost advantage over competitors, priced within the second-lowest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings MOON

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 32.9
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Recursion Pharmaceuticals Inc Class A

4.37 1.2 Mil
Healthcare

4D Molecular Therapeutics Inc Ordinary Shares

3.98 1.1 Mil
Healthcare

Avidity Biosciences Inc Ordinary Shares

3.97 1.1 Mil
Healthcare

Allogene Therapeutics Inc

3.69 979,522
Healthcare

Rumble Inc

3.39 900,914
Technology

Couchbase Inc

2.99 794,749
Technology

Coinbase Global Inc Ordinary Shares - Class A

2.75 730,469
Financial Services

Robinhood Markets Inc Class A

2.68 712,903
Financial Services

CRISPR Therapeutics AG

2.62 696,674
Healthcare

Roivant Sciences Ltd Ordinary Shares

2.51 666,662
Healthcare